Madrigal Pharmaceuticals Inc (NQ: MDGL )

212.26 -1.23 (-0.58%)

Streaming Delayed Price Updated: 9:52 AM EDT, Apr 23, 2024 Add to My Watchlist

Price and Volume

Volume	19,938
Open	212.82
Bid (Size)	210.83 (4)
Ask (Size)	213.56 (4)
Prev. Close	213.49
Today's Range	210.10 - 213.56
52wk Range	119.76 - 322.67
Shares Outstanding	17,103,395
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

6 Stocks Positioned to Soar as Investors Focus on MASH

April 22, 2024

Investors are making a lot of money on obesity plays. Obesity is at epidemic proportions, so it's easy to see why obesity drugs including GLP-1 agonists have exploded in the marketplace. This class of...

Via TheNewswire.com

7 Stocks Analysts Are Loving Right Now (And You Should Too): April 2024

April 15, 2024

Analyst-backed stocks have a high correlation with future stock price growth. Here are seven stocks with a high number of recent upgrades.

Via InvestorPlace

Performance

YTD	-6.44%	-6.44%
1 Month	-14.28%	-14.28%
3 Month	-8.97%	-8.97%
6 Month	+68.57%	+68.57%
1 Year	-30.61%	-30.61%

More News

2 Under-the-Radar Growth Stocks to Consider

April 10, 2024

Via The Motley Fool

Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics

April 05, 2024

Via The Motley Fool

1 No-Brainer Growth Stock to Buy Now

April 03, 2024

Via The Motley Fool

Here's 1 Huge New Reason to Buy Madrigal Pharmaceuticals Stock

March 26, 2024

Via The Motley Fool

Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 3/15 Morning Trading

March 15, 2024

Via Investor Brand Network

The 3 Best Biotech Stocks to Buy in April 2024

April 01, 2024

Via InvestorPlace

2 Top Biotech Buyout Candidates

March 31, 2024

Via Talk Markets

Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals

March 29, 2024

Via The Motley Fool

Is This Healthcare Stock a Screaming Buy After Scoring a Huge Drug Approval?

March 29, 2024

Via The Motley Fool

7 Stocks That Will Drive the Weight Loss Drugs Market

March 28, 2024

Via MarketBeat

This Under-the-Radar Stock Just Hit a Major Milestone: Time to Buy?

March 22, 2024

Via The Motley Fool

Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?

March 19, 2024

Via The Motley Fool

7 Biotech Stocks Ready to Ride the Sector’s Resurgence

March 18, 2024

Via InvestorPlace

Madrigal Pharmaceuticals Stock Hits 80-Plus Relative Strength Rating Benchmark

March 18, 2024

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session

March 18, 2024

Via Benzinga

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?

March 17, 2024

Via The Motley Fool

Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session

March 15, 2024

Via Benzinga

FDA Conditionally Approves Madrigal Pharmaceuticals' Resmetirom As First Treatment For Fatty Liver Disease With Scarring

March 15, 2024

Via Benzinga

Why Is Geron (GERN) Stock Up 94% Today?

March 15, 2024

Via InvestorPlace

Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday

March 15, 2024

Via Benzinga

MDGL Stock Alert: The Historic Reason Madrigal Is Up 19% Today

March 15, 2024

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session

March 15, 2024

Via Benzinga

Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket

March 15, 2024

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.